THU0305 Pharmacokinetics of Switching from Intravenous To Subcutaneous Belimumab for Patients with Systemic Lupus Erythematosus (SLE)
Sheikh, S.Z., Fox, N.L., Hammer, A.E., Struemper, H., Groark, J., Roth, D., Gordon, D.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
AB0416 Reliability and Safety of A Novel Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus (SLE)
Sheikh, S.Z., Fox, N.L., Hammer, A.E., Struemper, H., Groark, J., Roth, D., Gordon, D.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
THU0403 A Randomised, Open-Label Study to Evaluate the Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector
Struemper, H., Murtaugh, T., Gilbert, J., Barton, M.E., Fire, J., Groark, J., Fox, N.L., Roth, D., Gordon, D.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
P4.11E.28 Pharmacological Comparison of Dostarlimab and Pembrolizumab in Metastatic Non-Small Cell Lung Cancer in PERLA
Samant, T.S., Struemper, H., Franzese, R.C., Goulooze, B., Muliaditan, M., Melhem, M., Ghosh, S., Fastenrath, M., Stjepanovic, N., Szijgyarto, Z., Rathi, C., Mantero, A., Hanafin, P., Zajic, S., Yanamandra, N., Chung, C-w., Vlahovic, G.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis
Struemper, Herbert, Sale, Mark, Patel, Bela R, Østergaard, Mikkel, Österborg, Anders, Wierda, William G, Hagenbeek, Anton, Coiffier, Bertrand, Jewell, Roxanne C
Published in Journal of clinical pharmacology (01.07.2014)
Published in Journal of clinical pharmacology (01.07.2014)
Get more information
Journal Article
Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study
Österborg, Anders, Jewell, Roxanne C, Padmanabhan-Iyer, Swami, Kipps, Thomas J, Mayer, Jiří, Stilgenbauer, Stephan, Williams, Cathy D, Hellmann, Andrzej, Furman, Richard R, Robak, Tadeusz, Hillmen, Peter, Trnêný, Marek, Dyer, Martin J S, Piotrowska, Magdalena, Kozak, Tomas, Gupta, Ira V, Phillips, Jennifer L, Goldstein, Nancy, Struemper, Herbert, Losic, Nedjad, Lisby, Steen, Wierda, William G
Published in Haematologica (Roma) (01.08.2015)
Published in Haematologica (Roma) (01.08.2015)
Get full text
Journal Article
DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM)
Richardson, PG, Trudel, S, Callander, NS, Nooka, A, Song, K, Uttervall, K, Minnema, MC, Rodriguez-Otero, P, Struemper, H, Yeakey, A, de Oca, RM, Smith, LM, Jackson, N, Kaisermann, M, Im, E, Basile, FG, Ahlers, CM, Holkova, B, Gupta, I, Kremer, BE, Quach, H
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Get full text
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Conference Proceeding
Systems biology for battling rheumatoid arthritis: application of the Entelos PhysioLab platform
Rullmann, J A C, Struemper, H, Defranoux, N A, Ramanujan, S, Meeuwisse, C M L, van Elsas, A
Published in Systems biology (01.12.2005)
Published in Systems biology (01.12.2005)
Get more information
Journal Article